Gilead Sciences v. Meritain Health — Foreign-Market Drugs Can Infringe Despite Chemical Identity
The Fourth Circuit held that foreign-market Gilead drugs can be non-genuine under trademark law when their labeling and quality controls materially differ from authorized U.S. products.